Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Sight Sciences (SGHT) Receivables (2020 - 2025)

Sight Sciences (SGHT) has 6 years of Receivables data on record, last reported at $9.7 million in Q4 2025.

  • For Q4 2025, Receivables fell 9.65% year-over-year to $9.7 million; the TTM value through Dec 2025 reached $9.7 million, down 9.65%, while the annual FY2025 figure was $9.7 million, 9.65% down from the prior year.
  • Receivables reached $9.7 million in Q4 2025 per SGHT's latest filing, roughly flat from $9.7 million in the prior quarter.
  • Across five years, Receivables topped out at $19.9 million in Q2 2024 and bottomed at $6.9 million in Q2 2021.
  • Average Receivables over 5 years is $12.4 million, with a median of $10.8 million recorded in 2024.
  • Peak YoY movement for Receivables: surged 73.94% in 2022, then crashed 51.73% in 2025.
  • A 5-year view of Receivables shows it stood at $8.7 million in 2021, then soared by 73.94% to $15.1 million in 2022, then dropped by 5.67% to $14.3 million in 2023, then dropped by 24.52% to $10.8 million in 2024, then decreased by 9.65% to $9.7 million in 2025.
  • Per Business Quant database, its latest 3 readings for Receivables were $9.7 million in Q4 2025, $9.7 million in Q3 2025, and $9.6 million in Q2 2025.